Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC Felip, E., Vallieres, E., Zhou, C., Wakelee, H., Bondarenko, I., Sakai, H., Saito, H., Ursol, G., Kawaguchi, K., Liu, Y., Levchenko, E., Kislov, N., Reck, M., Liersch, R., McNally, V. A., Zhu, Q., Ding, B., Bennett, E., Gitlitz, B., Altorki, N. K. ELSEVIER. 2021: S1319
View details for DOI 10.1016/j.annonc.2021.08.2120
View details for Web of Science ID 000700527703519